The treatment of RA is staged. In the beginning the patient receives classical disease modifying anti-inflammatory drugs. If this treatment becomes ineffective, different and more advanced drugs are deployed. Treatment is usually to be guided by monitoring of disease activity, and if performed adequately, irreversible joint damage can be prevented and discomfort due to the disease and drug unwanted effects can be limited. As such monitoring of disease activity will help to reduce the general treatment costs which is definitely important given the chronic nature of RA. Related StoriesNo progression in joint damage in 84 percent of psoriatic arthritis patientsUniversity of Manchester scientists identify brain mechanism that raises discomfort thresholdAbbVie plans to advance ABT-494 to Stage 3 research in rheumatoid arthritisAbout Akeso Medical Imaging – Akeso Medical Imaging B.V.AboutActavis Actavis plc, headquartered inDublin, Ireland, is certainly a distinctive specialty pharmaceutical company centered on developing, manufacturing and commercializing top quality inexpensive generic and innovative top quality pharmaceutical products for patients around the world. Actavismarkets a broad portfolio of branded and generic pharmaceuticals and evolves innovative medicines for patients experiencing diseases principally in the central nervous system, gastroenterology, women's wellness, urology, cardiovascular, respiratory and anti-infective therapeutic categories.